Showing results (111-120 of 275) with videos related to
Sort By:
Pageof 28
The American Journal of Gastroenterology|May 11, 2002
Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia majorWilliam Sievert, Stephen Pianko, Shernyne Warner, et al.Virology|November 22, 2016
Stop codons in the hepatitis B surface proteins are enriched during antiviral therapy and are associated with host cell apoptosisDanielle Colledge, Sally Soppe, Lilly Yuen, et al.Gut|November 29, 2014
Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis BMichelle Giles, Kumar Visvanathan, Sharon Lewin, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 3, 2003
Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failureAnna Ayres, Angeline Bartholomeusz, George Lau, et al.Bulletin of the World Health Organization|April 30, 2010
Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?C John Clements, Ben Coghlan, Mick Creati, et al.Antimicrobial Agents and Chemotherapy|April 18, 2007
The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitroNadia Warner, Stephen Locarnini, Michael Kuiper, et al.Antiviral Research|December 6, 2011
Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunitsWan-Shoo Cheong, Michiko Hyakumura, Lilly Yuen, et al.JHEP Reports : Innovation in Hepatology|September 13, 2023
On-treatment risks of cirrhosis and hepatocellular carcinoma among a large cohort of predominantly non-Asian patients with non-cirrhotic chronic hepatitis BZeyuan Yang, Ramsey C Cheung, Amit S Chitnis, et al.BMJ Open Gastroenterology|October 14, 2015
Predictors of hepatic decompensation after TACE for hepatocellular carcinomaMohamed A S Kohla, Mai I Abu Zeid, Mohamed Al-Warraky, et al.Hepatology (Baltimore, Md.)|March 11, 2009
Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee modelSaleem Kamili, Vitini Sozzi, Geoff Thompson, et al.Pageof 28